Skip to content

Clinical study of electroacupuncture combined with three-step analgesic therapy in the treatment of moderate and severe pain of liver cancer

Clinical study of electroacupuncture combined with three-step analgesic therapy in the treatment of moderate and severe pain of liver cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001224
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-03-26
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Observation group:Basic treatment + Electroacupuncture Treatmentr

Sponsors

Yueyang Integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who met the diagnostic criteria for HCC; (2) Age = 30 and = 80 years old gender unlimited; (3) NRS score = 4 within 24h before screening; (4) Child Pugh grade A or B patients; (5) Patients with an expected survival of >3 months; (6) Have clear consciousness and be able to assess their own pain and quality of life; (7) Those who understand and agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with other physiological or pathological pain; (2) Patients who had undergone tumor resection in the past 3-6 months; (3) Patients with persistent ascites abdominal infection gastrointestinal bleeding liver failure abdominal bleeding and other serious complications; (4) Patients with severe acute and chronic organ diseases or mental disorders; (5) Patients with contraindications to electroacupuncture such as local skin damage particularly sensitive to current with cardiac pacemaker and cardiovascular stent; (6) Patients who had previously received electroacupuncture treatment; (7) Patients scheduled for surgery in the past 21 days. If any of the above conditions are met they will be excluded.

Design outcomes

Primary

MeasureTime frame
Effective rate of pain relief;

Secondary

MeasureTime frame
Analgesic dosage;Frequency of gastrointestinal side effects;Assessment of pain degree;Comprehensive evaluation of life quality;Number of bursts of pain;

Countries

China

Contacts

Public ContactZHU LU

Shanghai acupuncture and moxibustion Meridian Research Institute

601584345@qq.com15951891067

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026